Loading
Latest filing published 01 Feb 2022 for HOOKIPA Pharma Inc., €34k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Roman Necina is a declared insider of HOOKIPA Pharma Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 20 July 2020 to 1 February 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 1 February 2022 came the latest disclosure, a share grant for €34k in HOOKIPA Pharma Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration